CLAIRE PETZINGER: Open Payments
NPI 1740839166 · BEND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$480 in 29 payments from 9 companies in 2025. Trend: 2023 $325 · 2024 $505 · 2025 $480
Food & beverage: $480
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $281 |
| ARGENX US, INC. | 2 | $48 |
| Genentech USA, Inc. | 1 | $37 |
| UCB, Inc. | 1 | $28 |
| TG Therapeutics, Inc. | 1 | $20 |
| ACADIA Pharmaceuticals Inc | 1 | $19 |
| Cala Health, Inc. | 1 | $18 |
| Lundbeck LLC | 1 | $15 |
| SK Life Science, Inc. | 1 | $14 |
Products named: QULIPTA, UBRELVY, VYVGART HYTRULO, Ocrevus Zunovo, Rystiggo, BRIUMVI, NUPLAZID, Cala kIQ.
Industry payments across OR — which companies pay providers there.
